Active Cancer NIHR-supported project Digestion, Kidneys & Other Organs
A PrOspective RandoMIsed Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Selection in Adults with CROHN’s Disease: OMICROHN
About this grant
This summary is based on the grant title only — the full abstract was not available.
No substantive source abstract was published for this research project funded by NIHR.
Researchers
Fraser Cummings (Principal Investigator)
Related Research
Grants with similar aims, by meaning.
Investigation into the Interaction Between the Microbiome, Malnutrition, Genetics and Crohn’s Disease Treatment Efficacy
Defining microbial predictors of responsiveness to biologic therapies in Crohn’s disease and ulcerative colitis
CRUK/11/054:FOCUS 4 - Molecular selection of therapy in metastatic colorectal cancer: a molecularly stratified randomised controlled trial programme (supported by Stand Up To Cancer)(CA)
IBD-RESPONSE - Defining microbial predictors of responsiveness to biological therapies in Crohns disease and ulcerative colitis
A Multicenter, Randomized, Double-Blind, Parallel-Group Study to Assess the Efficacy and Safety of Oral Etrasimod as Induction and Maintenance Therapy for Moderately to Severely Active Crohn’s Disease
Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know